Global melasma treatment market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. Increase in strategic alliances between the pharmaceuticals companies and untapped emerging economies are the key factors that fueling the market growth. Few of the major competitors currently working in the global melasma treatment market are Glenmark Pharmaceuticals Ltd, Abbott, La Pristine Bioceuticals Pvt Ltd, Galderma Laboratories, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Wockhardt, mesoestetic, LUTRONIC, Cynosure Inc, Focus Medical and others.
Melasma is also known as chloasma faciei is skin discoloration condition causes brown patches on the face most commonly appearing on the cheeks, bridge of the nose, forehead, and chin. It also can appear on other parts of the body that get lots of sun. Hormone changes along with sun exposure are the most common triggers for melisma.
Click Here to Get the Inside Scoop and Research Methodology of this Sample Report Here
Market Drivers
-
High prevalence of melasma and vulnerable woman population is propelling the growth of this market
-
New innovation and emerging new markets is boosting the market growth
-
High demand of disease specific novel treatment can also act as a market driver
-
The competitive scenario of market and strategic collaborations may boost the market position
Segmentation: Global Melasma Treatment Market
By Type
-
Epidermal
-
Dermal
-
Mixed
-
Others
By Treatment
-
Medication
-
Hydroquinone
-
Azelaic Acid
-
Kojic Acid
-
Mequinol
-
Arbutin
-
-
Others
-
Laser Treatment
By Route of Administration
-
Oral
-
Topical
By End Users
-
Hospitals
-
Homecare
-
Others
By Distribution Channel
-
Hospital Pharmacy
-
Retail Pharmacy
-
Online Pharmacy
By Geography
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
South America
-
Brazil
-
Argentina
-
Peru
-
Rest of South America
-
-
Europe
-
Germany
-
France
-
United Kingdom
-
Italy
-
Spain
-
Russia
-
Turkey
-
Belgium
-
Netherlands
-
Switzerland
-
Hungary
-
Lithuania
-
Austria
-
Ireland
-
Norway
-
Poland
-
Rest of Europe
-
-
Asia-Pacific
-
Japan
-
China
-
South Korea
-
India
-
Australia
-
Singapore
-
Thailand
-
Malaysia
-
Indonesia
-
Philippines
-
Vietnam
-
Rest of Asia Pacific
-
-
Middle East & Africa
-
South Africa
-
UAE
-
Kuwait
-
Israel
-
Egypt
-
Rest of Middle East & Africa
-
Click Here to Get Complete Table of Content and Avail Exclusive Discount
Key Developments in the Market:
- In August 2016, Cynosure Inc announced new breakthrough aesthetic laser innovation for the treatment of melisma and body contouring laser treatment at Cynosure APAC Forum. This innovation can significantly change treatment paradigms and broadens the company’s aesthetic devices portfolio.
Competitive Analysis:
Global melasma treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares global melasma treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Players:
Few of the major competitors currently working in the global melasma treatment market are Glenmark Pharmaceuticals Ltd, Abbott, La Pristine Bioceuticals Pvt Ltd, Galderma Laboratories, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Wockhardt, mesoestetic, LUTRONIC, Cynosure Inc, Focus Medical and others.
